Ryman Healthcare Limited Stock Debt To Equity
| RH7 Stock | EUR 2.34 0.05 2.09% |
Ryman Healthcare Limited fundamentals help investors to digest information that contributes to Ryman Healthcare's financial success or failures. It also enables traders to predict the movement of Ryman Stock. The fundamental analysis module provides a way to measure Ryman Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ryman Healthcare stock.
Ryman |
Ryman Healthcare Limited Company Debt To Equity Analysis
Ryman Healthcare's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Ryman Healthcare Debt To Equity | 61.60 % |
Most of Ryman Healthcare's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ryman Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Ryman Healthcare Limited has a Debt To Equity of 61%. This is 15.05% higher than that of the Healthcare sector and 61.43% lower than that of the Long-Term Care Facilities industry. The debt to equity for all Germany stocks is 26.49% lower than that of the firm.
Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Ryman Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.82 B | |||
| Shares Outstanding | 530.46 M | |||
| Shares Owned By Insiders | 11.54 % | |||
| Shares Owned By Institutions | 16.69 % | |||
| Price To Earning | 15.33 X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 3.46 X | |||
| Revenue | 503.76 M | |||
| Gross Profit | 42.52 M | |||
| EBITDA | 788.44 M | |||
| Net Income | 692.87 M | |||
| Total Debt | 2.58 B | |||
| Debt To Equity | 61.60 % | |||
| Current Ratio | 0.64 X | |||
| Book Value Per Share | 7.26 X | |||
| Cash Flow From Operations | 585.98 M | |||
| Earnings Per Share | 0.66 X | |||
| Price To Earnings To Growth | 2.57 X | |||
| Number Of Employees | 6.8 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 1.99 B | |||
| Total Asset | 10.97 B | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 10.97 B | |||
| Last Dividend Paid | 0.22 |
About Ryman Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ryman Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ryman Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ryman Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Ryman Stock
Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.